Dr. Joshua Deleon, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York Downstate Medical Center (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 2,442
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: State University of New York Downstate Medical Center
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NY license 179286 -
Cardiovascular Disease Physician
NY license 179286
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- NYU Langone Hospitals New York, NY
- Long Island Community Hospital Patchogue, NY
Medical groups
- New York University (6,134 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,442
- Services billed
- 6,695
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,315 | 980 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 907 | 884 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 673 | 364 |
| Established patient office or other outpatient visit, 30-39 minutes | 505 | 290 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 416 | 49 |
| Injection, regadenoson, 0.1 mg | 248 | 62 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 208 | 201 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 190 | 95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 164 | 163 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 152 | 152 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Mineola, NY | 294 |
| Atorvastatin Calcium Other prescribers in Mineola, NY | 213 |
| Amlodipine Besylate Other prescribers in Mineola, NY | 161 |
| Carvedilol Other prescribers in Mineola, NY | 127 |
| Eliquis (apixaban) Other prescribers in Mineola, NY | 118 |
| Rosuvastatin Calcium Other prescribers in Mineola, NY | 113 |
| Losartan Potassium Other prescribers in Mineola, NY | 100 |
| Entresto (sacubitril/valsartan) Other prescribers in Mineola, NY | 77 |
| Furosemide Other prescribers in Mineola, NY | 75 |
| Ramipril Other prescribers in Mineola, NY | 70 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 10 payments worth $212 in total to this clinician.
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $126 |
|---|---|
| Novartis Pharmaceuticals Corporation | $40.59 |
| Pfizer Inc. | $26.07 |
| E.r. Squibb & Sons, L.l.c. | $18.92 |
| Food and Beverage | $212 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,481 in research payments for these studies, mostly to the institutions running them.
- Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.